Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.
2002
Preoperative pharmacological management of phaeochromocytoma.
2006
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
A role for helix 3of the TRbeta ligand-binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormone
1998
Prognostic Impact of Serum Calcitonin and Carcinoembryonic Antigen Doubling-Times in Patients with Medullary Thyroid Carcinoma
2005
Structure and specificity of nuclear receptor–coactivator interactions
1998
Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist
1999 Standout
The North American Neuroendocrine Tumor Society Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors
2010
Somatostatin and Somatostatin Receptor Subtype Gene Expression in Medullary Thyroid Carcinoma1
1998
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
Thyroid cancer
2016 Standout
Selective arterial chemoembolization for hepatic metastases from medullary thyroid carcinoma
2005
Novel insight from transgenic mice into thyroid hormone resistance and the regulation of thyrotropin
1999
Surgical Strategy for the Treatment of Medullary Thyroid Carcinoma
1999
Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times
2008
Intrinsically unstructured proteins and their functions
2005 Standout
Impact of Routine Measurement of Serum Calcitonin on the Diagnosis and Outcome of Medullary Thyroid Cancer: Experience in 10,864 Patients with Nodular Thyroid Disorders
2004
114mIn, a candidate for radionuclide therapy: low-energy cyclotron production and labeling of DTPA-D-Phe-octreotide
2000
The Thyroid Nodule
2004 Standout
Réintervention pour carcinome médullaire de la thyroïde : résultats à long terme
2001
Clinical and molecular aspects of adrenocortical tumourigenesis
2003
Medullary thyroid cancer: the role of radiotherapy in local control
1996
Cushing's syndrome
2001
Biology and management of the midgut carcinoid
1993
Medullary Thyroid Cancer
1995
Cushing's syndrome
2015 Standout
Phaeochromocytoma
2005 Standout
Functions of Thyroid Hormone Receptors in Mice
2000
CTLA-4: new insights into its biological function and use in tumor immunotherapy
2002 StandoutNobel
A Dominant-negative Peroxisome Proliferator-activated Receptor γ (PPARγ) Mutant Is a Constitutive Repressor and Inhibits PPARγ-mediated Adipogenesis
2000
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Comparison of phenoxybenzamine to sodium nitroprusside in infants undergoing surgery
2005
Phaeochromocytoma—recent progress in its management
2000
Surgical Management of Pheochromocytoma with the Use of Metyrosine
1990
Thyroid Hormone-mediated Enhancement of Heterodimer Formation between Thyroid Hormone Receptor β and Retinoid X Receptor
1997
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
2000 Standout
LONG‐TERM TREATMENT OF METASTATIC MEDULLARY THYROID CARCINOMA WITH THE SOMATOSTATIN ANALOGUE OCTREOTIDE
1990
Estimated Risk of Pheochromocytoma Recurrence After Adrenal-Sparing Surgery in Patients With Multiple Endocrine Neoplasia Type 2A
2006
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm
1999 Standout
Anti‐carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma
1997
Defective Release of Corepressor by Hinge Mutants of the Thyroid Hormone Receptor Found in Patients with Resistance to Thyroid Hormone
1998
Structure of the NCoA-1/SRC-1 PAS-B Domain Bound to the LXXLL Motif of the STAT6 Transactivation Domain
2004 StandoutNobel
Das medulläre Schilddrüsenkarzinom
2015
Advances in the management of hereditary medullary thyroid cancer
2004
Somatostatin receptor imaging in persistent medullary thyroid carcinoma
1995
Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours
2004
The Acidic Transcription Activator Gcn4 Binds the Mediator Subunit Gal11/Med15 Using a Simple Protein Interface Forming a Fuzzy Complex
2011 StandoutNobel
Laparoscopic detection of hepatic metastases in patients with residual or recurrent medullary thyroid cancer
1995
Nuclear receptors: coactivators, corepressors and chromatin remodeling in the control of transcription
1999
A 5‐decade analysis of 13,715 carcinoid tumors
2003 Standout
Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors
2005
Treatment of medullary thyroid carcinoma: an update.
2001
Postoperative calcitonin study in medullary thyroid carcinoma.
2004
Long-term Results of Reoperation and Localizing Studies in Patients With Persistent or Recurrent Medullary Thyroid Cancer
2000
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen
1998 Standout
A Dominant Negative Peroxisome Proliferator-activated Receptor-γ Knock-in Mouse Exhibits Features of the Metabolic Syndrome
2005
Interventional treatment of neuroendocrine liver metastases
2008
Contralateral cervical and mediastinal lymph node metastasis in medullary thyroid cancer: Systemic disease?
2005
Functional Genomic Analysis of C. elegans Molting
2005 StandoutNobel
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
Management of Pheochromocytomas in Patients with Multiple Endocrine Neoplasia Type 2 Syndromes
1993
Clinical aspects of SDHx-related pheochromocytoma and paraganglioma
2009
Cushing's syndrome
2006 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
A Novel TRβ Mutation (R383H) in Resistance to Thyroid Hormone Syndrome Predominantly Impairs Corepressor Release and Negative Transcriptional Regulation
1998
Management and Treatment of Pheochromocytomas and Paragangliomas
2006
Atomic structure of progesterone complexed with its receptor
1998 Nature
Improved Results of Cervical Reoperation for Medullary Thyroid Carcinoma
1997
The surgical treatment of medullary thyroid carcinoma
1999
A Regulatory Role for RIP140 in Nuclear Receptor Activation
1998
A Five-Year Report on Experience in the Detection of Pheochromocytoma
2000
Isolation and Characterization of a Novel Ligand-dependent Thyroid Hormone Receptor-coactivating Protein
1997
SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma–paraganglioma syndromes
2009
Surgery as primary treatment in patients with liver metastases from carcinoid tumors: A retrospective, unicentric study over 13 years
2001
Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis
2000
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
The Role of Radiotherapy in the Management of Elevated Calcitonin After Surgery for Medullary Thyroid Cancer
2001
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
EcR isoforms inDrosophila: testing tissue-specific requirements by targeted blockade and rescue
2002
Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid: A retrospective study of 109 consecutive patients
1996
Augmentation of T Cell Levels and Responses Induced by Androgen Deprivation
2004 StandoutNobel
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
A Novel Natural Mutation in the Thyroid Hormone Receptor Defines a Dual Functional Domain That Exchanges Nuclear Receptor Corepressors and Coactivators
1998
Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors
1998
The Relative Proportion of Stromal and Epithelial Hyperplasia is Related to the Development of Symptomatic Benign Prostate Hyperplasia
1992
Ligand-dependent interactions of coactivators steroid receptor coactivator-1 and peroxisome proliferator-activated receptor binding protein with nuclear hormone receptors can be imaged in live cells and are required for transcription
2000 StandoutNobel
Preoperative Management of the Pheochromocytoma Patient
2007
Thyroid Cancer Nodal Metastases: Biologic Significance and Therapeutic Considerations
1996
Hormone-Dependent Coactivator Binding to a Hydrophobic Cleft on Nuclear Receptors
1998 Science
Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model.
1999
DAF-16 recruits the CREB-binding protein coactivator complex to the insulin-like growth factor binding protein 1 promoter in HepG2 cells
2000 StandoutNobel
Nuclear Receptors and Lipid Physiology: Opening the X-Files
2001 StandoutScience
Transcriptional regulation of adipogenesis
2000 Standout
Medullary Thyroid Carcinoma
1998
Medullary Thyroid Carcinoma: Management of Lymph Node Metastases
2010
The coregulator exchange in transcriptional functions of nuclear receptors
2000 Standout
Histone Acetyltransferases
2001 Standout
Improved Diagnostic Methods in the Follow-Up of Medullary Thyroid Carcinoma by Highly Specific Calcitonin Measurements*
2000
Surgical management of patients with persistent or recurrent medullary thyroid cancer
1998
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Physiological and Molecular Basis of Thyroid Hormone Action
2001 Standout
Mechanisms of Estrogen Action
2001 Standout
In Vivo Interaction of Steroid Receptor Coactivator (SRC)-1 and the Activation Function-2 Domain of the Thyroid Hormone Receptor (TR) β in TRβ E457A Knock-In and SRC-1 Knockout mice
2009
T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer
2001
SUCCESSFUL OUTCOMES IN PHEOCHROMOCYTOMA SURGERY IN THE MODERN ERA
1999
Multifunctional Envelope-Type siRNA Delivery Nanoparticle Platform for Prostate Cancer Therapy
2017
Latent Subclinical Medullary Thyroid Carcinoma: Diagnosis and Treatment
1998
110mIn-DTPA-D-Phe1-octreotide for imaging of neuroendocrine tumors with PET.
2002
Thyroid Hormone Regulation of Metabolism
2014 Standout
Adrenal cortical carcinoma
2001
Analysis of the Functional Role of Steroid Receptor Coactivator-1 in Ligand-Induced Transactivation by Thyroid Hormone Receptor
1997
The Metabolic Syndrome
2008 Standout
Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma
1997
Prophylactic Thyroidectomy in MEN 2A Syndrome: Experience in a Single Center1
2002
The Oxytocin Receptor System: Structure, Function, and Regulation
2001 Standout
Direct Interactions between Corepressors and Coactivators Permit the Integration of Nuclear Receptor-Mediated Repression and Activation
2002
Lack of Coactivator Interaction Can Be a Mechanism for Dominant Negative Activity by Mutant Thyroid Hormone Receptors
1998
Succinate Dehydrogenase B Gene Mutations Predict Survival in Patients with Malignant Pheochromocytomas or Paragangliomas
2007
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
1999 Standout
Identification, Quantification, and Localization of mRNA for Three Distinct Alpha1Adrenergic Receptor Subtypes in Human Prostate
1993 StandoutNobel
The Development of Human Benign Prostatic Hyperplasia with Age
1984 Standout
Lack of Coactivator Interaction Can Be a Mechanism for Dominant Negative Activity by Mutant Thyroid Hormone Receptors**This work was supported by the March of Dimes Foundation.
1998
Long‐term Outcome of Reoperations for Medullary Thyroid Carcinoma
2008
The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management
2004
Part 14: Pediatric Advanced Life Support
2010 Standout
Surgery and Radiofrequency Ablation for Treatment of Liver Metastases from Midgut and Foregut Carcinoids and Endocrine Pancreatic Tumors
2008
Medullary thyroid carcinoma in Hong Kong Chinese patients.
2005
Cloning and Characterization of Mouse RIP140, a Corepressor for Nuclear Orphan Receptor TR2
1998
Thyroid carcinoma
2003 Standout
Effect of Surgery on the Outcome of Midgut Carcinoid Disease with Lymph Node and Liver Metastases
2002
Surgery for lymph node metastases of medullary thyroid carcinoma: A review
2015
Evidence‐based Approach to the Management of Sporadic Medullary Thyroid Carcinoma
2007
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Works of L E Tisell being referenced
Reoperation for recurrent or persistent medullary thyroid cancer.
1993
Concentration and content of zinc in the human prostate.
1980
Hepatic arterial embolisation in the treatment of the midgut carcinoid syndrome and other advanced endocrine tumours metastatic to the liver
1990
Management of Disseminated Midgut Carcinoid Tumours
1991
The Ki67 index a prognostic marker in medullary thyroid carcinoma
2003
Progression of postoperative residual medullary thyroid carcinoma as monitored by plasma calcitonin levels
1996
Long‐term outcome of a large series of patients surgically treated for pheochromocytoma
2005
Comparison of survival between malignant neuroendocrine tumours of midgut and pancreatic origin
1999
The Use of a Long-Acting Somatostatin Analogue in the Treatment of Advanced Endocrine Malignancies with Gastrointestinal Symptoms
1987
A natural transactivation mutation in the thyroid hormone β receptor: Impaired interaction with putative transcriptional mediators
1997
Somatostatin receptor scintigraphy in medullary thyroid carcinoma
1997
Somatostatin Receptors in the Diagnosis and Therapy of Neuroendocrine Tumors
1997
Early diagnosis of and surgical strategy for adrenal medullary disease in MEN II gene carriers.
1988
The Weight of the Dorsal, Lateral and Medial Prostatic Lobes in Man
1979
Influence of Pre‐operative Treatment with Phenoxybenzamine on the Incidence of Adverse Cardiovascular Reactions during Anaesthesia and Surgery for Phaeochromocytoma
1985
Adrenocortical Carcinoma: Surgery and Mitotane for Treatment and Steroid Profiles for Follow‐up
1998
Systemic radionuclide therapy using indium-111-DTPA-D-Phe1-octreotide in midgut carcinoid syndrome.
1996
The Weight of the Human Prostate
1979
Survival of Patients with Disseminated Midgut Carcinoid Tumors after Aggressive Tumor Reduction
1996
Autotransplantation of diseased parathyroid glands into subcutaneous abdominal adipose tissue.
1987
Somatostatin receptor scintigraphy in medullary thyroid carcinoma
1997